These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26037881)

  • 41. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y; Guo Z; Kalsekar I; Forbes RA; Hebden T; Thase ME
    Int Clin Psychopharmacol; 2013 Mar; 28(2):87-90. PubMed ID: 23262644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adjunctive aripiprazole for depression: predictive value of early assessment.
    Muzina DJ; Chambers JS; Camacho TA; Eudicone JM; Forbes RA; Berman RM; Baker RA
    Am J Manag Care; 2011 Dec; 17(12):793-801. PubMed ID: 22216750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex.
    Chu CS; Tzeng NS; Chang HA; Chang CC; Chen TY
    Med Hypotheses; 2014 Sep; 83(3):407-9. PubMed ID: 25109873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of Kleine-Levin Syndrome with Aripiprazole.
    Yılmaz S; Akça ÖF; Bilgiç A
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):450-1. PubMed ID: 26091200
    [No Abstract]   [Full Text] [Related]  

  • 46. Aripiprazole, hypertension, and confusion.
    Pitchot W; Ansseau M
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E33. PubMed ID: 20160240
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of aripiprazole augmentation for depressive symptoms changes with progression of Lewy body disease.
    Iwamoto K; Fujishiro H; Ozaki N
    Psychiatry Clin Neurosci; 2017 Jan; 71(1):74-75. PubMed ID: 27862744
    [No Abstract]   [Full Text] [Related]  

  • 48. Brexpiprazole: another multipurpose antipsychotic drug?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Apr; 53(4):23-5. PubMed ID: 25856810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of aripiprazole in treating obsessive compulsive symptoms.
    Yang KC; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):585-6. PubMed ID: 18037548
    [No Abstract]   [Full Text] [Related]  

  • 51. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical antipsychotics in the treatment of mood disorders.
    Jarema M
    Curr Opin Psychiatry; 2007 Jan; 20(1):23-9. PubMed ID: 17143078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
    Katzman MA
    J Affect Disord; 2011 Jan; 128 Suppl 1():S11-20. PubMed ID: 21220076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
    Weisler RH; Khan A; Trivedi MH; Yang H; Eudicone JM; Pikalov A; Tran QV; Berman RM; Carlson BX
    J Clin Psychiatry; 2011 Apr; 72(4):548-55. PubMed ID: 20816039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of frontotemporal dementia with sexual disinhibition controlled by aripiprazole.
    Nomoto H; Matsubara Y; Ichimiya Y; Arai H
    Psychogeriatrics; 2017 Nov; 17(6):509-510. PubMed ID: 28745408
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-Dose Aripiprazole Augmentation in the Treatment of Burning Mouth Syndrome: A Case Report.
    Uzun Ö; Bolu A
    Clin Neuropharmacol; 2020; 43(3):92. PubMed ID: 32217865
    [No Abstract]   [Full Text] [Related]  

  • 59. Aripiprazole Use in Children Diagnosed with Down Syndrome and Comorbid Autism Spectrum Disorders.
    Bacanli A
    J Child Adolesc Psychopharmacol; 2016 Apr; 26(3):306-8. PubMed ID: 26870907
    [No Abstract]   [Full Text] [Related]  

  • 60. Reversal of trichotillomania with aripiprazole.
    Jefferys D; Burrows G
    Depress Anxiety; 2008; 25(6):E37-40. PubMed ID: 17941109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.